Descrição

De acordo com um relatório da StrategyHelix, the global 3d bioprinting market is set to increase by US$ 1,538.1 milhões durante 2022-2028, crescendo em um CAGR de 17.3% durante o período de previsão.

O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2018-2021 e previsão para 2028 covering key market aspects like sales value for 3d bioprinting. The global 3d bioprinting market is segmented on the basis of components, tecnologia, material, aplicativo, usuário final, and region. On the basis of components, the global 3d bioprinting market has been segmented into 3D bioprinters, bioinks. By technology, the global 3d bioprinting market has been segmented into inkjet bioprinting, laser assisted bioprinting, magnetic levitation bioprinting, syringe/extrusion bioprinting, outros. Based on material, the global 3d bioprinting market is categorized into extracellular matrices, hydrogels, living cells, outros. On the basis of application, the global 3d bioprinting market has been segmented into clinical, research. Por usuário final, the global 3d bioprinting market has been segmented into biopharmaceutical companies, regenerative medicine companies, research organizations & academic institutes, outros. Geographically, the global 3d bioprinting market is segmented into Asia Pacific, Europa, América do Norte, Rest of the World (RoW).

The global 3d bioprinting market is highly competitive. The prominent players operating in the global 3d bioprinting market include 3D Systems Corporation (Allevi Inc.), Advanced Solutions Life Sciences LLC (ASLS), Aspect Biosystems Ltd., BICO Group AB (Formerly Cellink AB), Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSIM GmbH, Inventia Life Science Pty Ltd., Nano3D Biosciences Inc. (n3D), Organovo Holdings Inc., Poietis SAS, regenHU Ltd., Regenovo Biotechnology Co. Ltda., ROKIT Healthcare INC., Stratasys Ltd., Vivax Bio LLC (3D Bioprinting Solutions). Competitive landscape gives a description of the competitive nature of the global 3d bioprinting market and a description of the leading companies. Os principais negócios financeiros que moldaram o mercado nos últimos anos são identificados.

O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the 3d bioprinting market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.

Escopo do relatório

Componentes: 3D bioprinters, bioinks
Tecnologia: inkjet bioprinting, laser assisted bioprinting, magnetic levitation bioprinting, syringe/extrusion bioprinting, outros
Material: extracellular matrices, hydrogels, living cells, outros
Aplicativo: clínico, research
Usuário final: biopharmaceutical companies, regenerative medicine companies, research organizations & academic institutes, outros
Região: Ásia-Pacífico, Europa, América do Norte, Rest of the World (RoW)
Anos considerados: este relatório cobre o período 2018 para 2028
Empresa mencionada: 3D Systems Corporation (Allevi Inc.), Advanced Solutions Life Sciences LLC (ASLS), Aspect Biosystems Ltd., BICO Group AB (Formerly Cellink AB), Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSIM GmbH, Inventia Life Science Pty Ltd., Nano3D Biosciences Inc. (n3D), Organovo Holdings Inc., Poietis SAS, regenHU Ltd., Regenovo Biotechnology Co. Ltda., ROKIT Healthcare INC., Stratasys Ltd., Vivax Bio LLC (3D Bioprinting Solutions)

Principais benefícios para as partes interessadas

– Get a comprehensive picture of the global 3d bioprinting market
– Identificar estratégias regionais e prioridades estratégicas com base em dados locais
– Identifique setores de crescimento e tendências para investimento

Índice

Papel 1. Introdução
– Escopo do estudo
– Período de estudos
– Escopo geográfico
– Metodologia de Pesquisa
Papel 2. 3d bioprinting market overview
Papel 3. Market breakdown by components
– 3D bioprinters
– Bioinks
Papel 4. Market breakdown by technology
– Inkjet bioprinting
– Laser assisted bioprinting
– Magnetic levitation bioprinting
– Syringe/extrusion bioprinting
– Outros
Papel 5. Market breakdown by material
– Extracellular matrices
– Hydrogels
– Living cells
– Outros
Papel 6. Market breakdown by application
– Clínico
– Research
Papel 7. Detalhamento do mercado por usuário final
– Biopharmaceutical companies
– Regenerative medicine companies
– Research organizations & academic institutes
– Outros
Papel 8. Market breakdown by region
– Ásia-Pacífico
– Europa
– América do Norte
– Rest of the World (RoW)
Papel 9. Principais empresas
– 3D Systems Corporation (Allevi, Inc.)
– Advanced Solutions Life Sciences, LLC (ASLS)
– Aspect Biosystems Ltd.
– BICO Group AB (Formerly Cellink AB)
– Cyfuse Biomedical K.K.
– EnvisionTEC GmbH (Desktop Metal Inc.)
– GeSIM GmbH
– Inventia Life Science Pty Ltd.
– Nano3D Biosciences, Inc.. (n3D)
– Organovo Holdings Inc.
– Poietis SAS
– regenHU Ltd.
– Regenovo Biotechnology Co., Ltda.
– ROKIT Healthcare, INC.
– Stratasys Ltd.
– Vivax Bio, LLC (3D Bioprinting Solutions)
Sobre StrategyHelix
Isenção de responsabilidade